Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GNF-5837 |
| Synonyms | |
| Therapy Description |
GNF-5837 is a small molecule inhibitor of tropomyosin receptor kinases NTRK1 (TRKA), NTRK2 (TRKB), and NTRK3 (TRKC), preventing proliferation of cancer cell models (PMID: 24900443, PMID: 31485624). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GNF-5837 | Trk Receptor Inhibitor (Pan) 33 | GNF-5837 is a small molecule inhibitor of tropomyosin receptor kinases NTRK1 (TRKA), NTRK2 (TRKB), and NTRK3 (TRKC), preventing proliferation of cancer cell models (PMID: 24900443, PMID: 31485624). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| NTRK1 positive | gastrointestinal system cancer | sensitive | GNF-5837 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, GNF-5837 prevented proliferation of transformed rat intestinal epithelial cells expressing Ntrk1 in culture and in xenograft mouse models (PMID: 24900443). | 24900443 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|